Get the Stockscreener App
392.86
0.98%
-3.89
After Hours:
393.00
0.14
+0.04%
Overview
News
Price History
Option Chain
Financials
Why HUM Down?
Discussions
Forecast
Dividend History
Humana Inc stock is traded at $392.86, with a volume of 1.31M.
It is down -0.98% in the last 24 hours and up +12.22% over the past month.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
See More
Previous Close:
$396.75
Open:
$398
24h Volume:
1.31M
Relative Volume:
0.78
Market Cap:
$47.17B
Revenue:
$137.20B
Net Income/Loss:
$1.15B
P/E Ratio:
42.04
EPS:
9.3439
Net Cash Flow:
$1.27B
1W Performance:
+1.02%
1M Performance:
+12.22%
6M Performance:
+40.39%
1Y Performance:
+63.91%
1-Day Range:
$388.10
$400.00
1-Week Range:
$385.84
$415.00
52-Week Range:
$163.11
$415.00
Humana Inc Stock (HUM) Company Profile
Name
Humana Inc
Sector
Industry
Phone
(502) 580-1000
Address
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, ELV, CI
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
392.86 | 47.69B | 137.20B | 1.15B | 1.27B | 9.3439 |
UNH
Unitedhealth Group Inc
|
417.99 | 377.45B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
102.08 | 131.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
408.17 | 83.98B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
281.98 | 72.93B | 278.13B | 6.74B | 7.66B | 23.60 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-02-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-07-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-05-25 | Upgrade | Jefferies | Hold → Buy |
| Oct-14-25 | Initiated | Goldman | Sell |
| Sep-22-25 | Initiated | Evercore ISI | In-line |
| May-01-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-06-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Oct-08-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-07-24 | Downgrade | Jefferies | Buy → Hold |
| Oct-07-24 | Downgrade | TD Cowen | Buy → Hold |
| Oct-03-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-02-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-02-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-22-24 | Initiated | Raymond James | Mkt Perform |
| Mar-13-24 | Downgrade | Argus | Buy → Hold |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Jan-26-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-25-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-23 | Upgrade | Argus | Hold → Buy |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-07-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-23-23 | Downgrade | Argus | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Oct-26-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-20-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Initiated | Bernstein | Mkt Perform |
| Apr-13-22 | Upgrade | UBS | Neutral → Buy |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-04-21 | Reiterated | Barclays | Overweight |
| Nov-04-21 | Reiterated | Credit Suisse | Outperform |
| Nov-04-21 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-21 | Reiterated | Oppenheimer | Outperform |
| Nov-04-21 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Sep-09-21 | Resumed | Barclays | Overweight |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jan-04-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-02-20 | Initiated | Bernstein | Mkt Perform |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-16-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jun-05-20 | Initiated | Goldman | Buy |
| Jan-03-20 | Reiterated | JP Morgan | Overweight |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-12-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Apr-23-19 | Initiated | UBS | Neutral |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-20-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-08-18 | Reiterated | BofA/Merrill | Buy |
| Sep-13-18 | Initiated | Barclays | Overweight |
| Jul-12-18 | Resumed | Morgan Stanley | Overweight |
| Jul-06-18 | Reiterated | Piper Jaffray | Overweight |
| Jun-01-18 | Resumed | Citigroup | Buy |
| Feb-08-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-08-18 | Reiterated | Leerink Partners | Outperform |
| Jan-12-18 | Upgrade | Jefferies | Hold → Buy |
View All
Humana Inc Stock (HUM) Latest News
Humana Inc (HUM) Shares Surge 3.1% -- What GF Score of 87 Tells Investors - GuruFocus
Humana, Centene lead healthcare rally in Q2 over Medicare Advantage optimism - Seeking Alpha
The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants - Business Wire
How CenterWell Is Driving Humana's Growth Beyond Insurance - Zacks Investment Research
2026-06-28 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Humana Inc. (HUM) and Encourages Shareholders to Learn More About the Investigation | NYSE:HUM | Press Release - Stockhouse
Humana Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Humana Inc. Actuals & Estimates (MUN:HUM) - TradingView
Humana stock hits 52-week high at 381.2 USD By Investing.com - Investing.com Nigeria
Humana stock hits 52-week high at 381.2 USD - Investing.com
Humana Inc. Actuals & Estimates (BMV:HUM) - TradingView
Humana Inc. (HUM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Humana Inc. Actuals & Estimates (XETR:HUM) - TradingView
Humana Inc. Actuals & Estimates (BIVA:HUM) - TradingView
Humana Inc.: - marketscreener.com
A Look at Humana Inc (HUM) After 4.0% Gain -- GF Value $362.88 v - GuruFocus
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Health Insurance Providers Stocks Q1 Results: Benchmarking Humana (NYSE:HUM) - Yahoo Finance
Price to sales forward of Humana Inc. – NYSE:HUM - TradingView
Humana Inc. $HUM Shares Sold by Leeward Investments LLC MA - MarketBeat
Price to earnings forward of Humana Inc. – NYSE:HUM - TradingView
Did Humana’s (HUM) Illinois Medicaid Win and MA Uncertainty Just Rebalance Its Risk Profile? - simplywall.st
UnitedHealth, Humana and CVS denied post-hospital care at some of the highest rates - Medical Xpress
Can Humana's Margin Recovery Drive Long-Term Earnings Growth? - The Globe and Mail
UnitedHealth, Humana And CVS Denied Post-Hospital Care At Some Of The Highest Rates - U.S. News & World Report
HUM News | HUMANA INC (NYSE:HUM) - ChartMill
Humana Inc. Stock 12‑Month Price Target Raised to $301.12, Implies 16% Downside - TradingView
Humana Inc. (HUM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Humana Inc. (NYSE: HUM) Investor Alert - marketscreener.com
Here’s What Hit Humana (HUM) in Q1 - Insider Monkey
symbol__ Stock Quote Price and Forecast - CNN
Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026 - Humana
Humana Inc. (NYSE: HUM) Investor Alert: Possible False Statements and Insider Sales - Schubert Jonckheer & Kolbe
Deals tracker: Hackensack Meridian Health explores merger - Modern Healthcare
UnitedHealth vs. Humana: Which Healthcare Leader Is a Better Bet Now? - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Is Investigating Humana Inc. (HUM) And Encourages Investors to Connect - ACCESS Newswire
UnitedHealth (UNH) Joins Optura As Former Humana And CVS Chiefs Sign On - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages Humana Inc. (HUM) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound - Investing.com
Humana says will not bid for Centene Corp - Yahoo Finance
Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State - Humana
Humana Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Humana (HUM) Chosen for HealthChoice Illinois Medicaid Program - GuruFocus
Humana wins Illinois Medicaid contract for statewide coverage - Investing.com
Humana wins Illinois Medicaid contract for statewide coverage By Investing.com - Investing.com Canada
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Humana Inc. (HUM) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Humana Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Humana, CenterWell and National Hispanic Medical Association Announce 2026 Resident Physician Scholarship Program Recipients - Business Wire
Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc.HUM - Business Wire
Humana employees donate $1.4M - The Business Journals
UBS reiterates Humana stock rating on utilization trends By Investing.com - Investing.com Canada
UBS reiterates Humana stock rating on utilization trends - Investing.com
Humana Inc Stock (HUM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Humana Inc Stock (HUM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ventura Joseph C | Chief Legal Officer |
Feb 24 '26 |
Option Exercise |
0.00 |
1,035 |
0 |
17,565 |
| Renaudin George II | President, Insurance |
Feb 24 '26 |
Option Exercise |
0.00 |
1,035 |
0 |
16,494 |
| Felter John-Paul W. | SVP, Chief Accting Off & Cont. |
Feb 24 '26 |
Option Exercise |
0.00 |
165 |
0 |
7,568 |
| Shetty Sanjay K | President, CenterWell |
Feb 23 '26 |
Buy |
185.21 |
810 |
150,016 |
11,657 |
| Dintenfass David | President, Enterprise Growth |
Feb 21 '26 |
Option Exercise |
0.00 |
3,858 |
0 |
15,316 |
| Mehta Japan | Chief Information Officer |
Feb 13 '26 |
Option Exercise |
0.00 |
1,682 |
0 |
8,158 |
| Mellet Celeste | Chief Financial Officer |
Feb 13 '26 |
Option Exercise |
0.00 |
7,763 |
0 |
28,454 |
| Rechtin James A. | President & CEO |
Jan 08 '26 |
Option Exercise |
0.00 |
2,183 |
0 |
29,285 |
| O'Hara Michelle A. | Chief Human Resources Officer |
Jan 01 '26 |
Option Exercise |
0.00 |
2,353 |
0 |
10,634 |
| Mellet Celeste | Chief Financial Officer |
Dec 15 '25 |
Option Exercise |
0.00 |
2,128 |
0 |
29,676 |
2.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):